Pfizer Stomach-Cancer Drug Succeeds in Trial (Reuters)


Reuters - Pfizer Inc. said on Tuesday its
experimental drug for a deadly form of stomach cancer proved
safe and effective in a late-stage trial, prompting researchers
to halt the study seven months ahead of schedule.

Read more...